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Abstract 
The most common type of stroke is ischemic stroke. Given that death due to 
stroke is one of the three leading causes of death globally, it is essential to 
identify its risk factors, especially modifiable risk factors. Nowadays, High 
homocysteine is recognized as one of the risk factors for stroke. Our aim in 
this study was to investigate the association between homocysteine levels and 
ischemic stroke. We searched the keywords in Scopus, Web of Science, 
Google Scholar, PubMed, and Science Direct with a 15-year time limit. At 
first, 3884 studies were found, and after further investigation and based on 
inclusion and exclusion criteria, only nine studies were selected. Of the nine 
selected studies was a clinical trial and eight observational studies, and in 
total, there were 16227 participants in these studies. The prevalence of 
ischemic stroke was higher in people with high homocysteine levels than in 
people with normal homocysteine levels (14.1% vs. 9.8%). The prevalence 
was generally higher in men, but among people with high homocysteine 
levels, the prevalence of ischemic stroke was slightly higher in women than 
in men (12% vs. 11%), and also, in women and men, the prevalence of 
ischemic stroke was higher in people with high homocysteine levels than in 
people with normal levels. Based on selected studies, increased homocysteine 
levels in men and women increases the risk of ischemic stroke. Because 
homocysteine levels are a modifiable risk factor, diet and prevention of 
vitamin B12 decrease can help prevent an increased risk of ischemic stroke. 
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Death of some neuron cells and their dysfunction due 
to lack of oxygen can lead to a brain stroke, which 
can change the body's function or perception of its 
condition (1, 2). Stroke is divided into hemorrhagic 
and ischemic due to the Pathological processes that 
occur (3). The most common type of stroke is 
ischemic stroke, which causes 85% of strokes. 
Ischemic stroke (IS) is caused by an obstruction in 
one of the brain arteries that can cause cell death (1, 
4). 
Determining the risk factors and treatment of 
stroke depends on its specific pathogenesis. Risk 
factors for IS can be divided into modifiable and non-
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modifiable types. Non-modifiable risk factors 
including sex, age, ethnicity, inherited diseases, 
family history, and low birth weight, and modifiable 
risk factors including smoking, high blood pressure, 
diet, physical inactivity, metabolic syndrome, and 
dyslipidemia, heart disease, body mass index, and 
alcohol consumption (5-7). The results of studies 
show that controlling for modifiable risk factors 
prevents ischemic stroke (8, 9). 
High homocysteine can increase oxidative 
stress, reduce vasodilation, stimulate vascular smooth 
muscle cell proliferation, and alter the elastic 
properties of vascular walls, which ultimately 
increase the risk of atherosclerosis (10). Therefore, in 
addition to the common risk factors mentioned in the 
previous paragraph, plasma homocysteine can also be 
considered as one of the risk factors for IS (11). A 
study by Wang et al. (12) shows that the rate of IS is 
higher in people with high homocysteine levels 
(hHcy) than in people with normal homocysteine 
levels (nHcy). Another study on this subject was 
conducted in 2020 (13), which confirms the claim of 
the previous study. However, a study by Halddin et al. 
in Sweden (14) shows that the rate of IS is slightly 
higher in people with nHcy than in those with hHcy. 
This systematic review study aimed to 
investigate the association between IS in people with 
hHcy and nHcy, given that homocysteine levels in 
individuals can be modified, and its modification can 
decrease the incidence of stroke. Therefore, it is 
necessary to carefully survey the studies to determine 




The present systematic review study was performed 
based on the PRISMA checklist (15). To avoid any 
bias in the study in the search process, study selection 
for inclusion in the study, assessment of article 
quality, and data extraction were used by two authors 
(PP) and (AS) and in case of any disagreement 
between the two authors from the author's comments 
third (MA) was used. 
 
Search Strategy: We searched the keywords 
"Homocysteine", "Hcy", "plasma Homocysteine", 
"plasma Hcy", "ischemic stroke", "cerebral ischemia", 
"brain ischemia" and "stroke" in PubMed, web of 
science, Scopus, Science Direct and Google scholar 
databases. To be sure, the sources of the selected 
articles for data mining were also manually reviewed 
so that a study would not be missed.  Search results 
were limited to English and articles in languages other 
were excluded. First, duplicate articles from the study 
selection process were removed, then the title and 
abstract of the articles were carefully reviewed, and 
articles with titles and abstracts unrelated to our aims 
and subject were excluded from the study. Finally, the 
full text of the remaining articles was carefully 
studied, and articles were selected using the inclusion 
and exclusion criteria of the studies and after 
evaluating their quality, the required data were 
extracted. We considered the 15-year time limit for 
search, so we only reviewed articles from 2005 to 
October 2020.  
 
Study Selection: PICOT (Population, Intervention, 
Comparison, Outcome, and Time) was used as a 
criterion for entering articles into the study (Table1), 
and original research articles were reviewed based on 
the PICOT criteria. The exclusion criteria excluded 
articles without full text, duplicate articles, case 
reports, letters to the editor, commentaries, editorials, 
case series, animal studies, conference abstracts, and 
articles other than English. In some studies, stroke 
was not of the IS type, or IS data were 
indistinguishable from data on other types of stroke 
were excluded. Also, articles that examined the 
association of homocysteine levels only with the 
severity or recurrence of ischemic stroke were 
excluded. Several studies have examined the 
association between homocysteine levels and IS in 
people with other diseases, such as diabetes or high 
blood pressure. These studies were also excluded. 
 
Quality assessment and Data extraction: After 
reviewing the full text of the selected articles, nine 
articles were selected for quality assessment. The 
CONSORT (16) and STROBE (17) checklists were 
used for quality assessment.  The CONSORT 
checklist was used to evaluate one study and the 
STROBE checklist was used for the other eight 
studies. Extraction of data related to the first author, 
year of publication of the article, countries in which 
studies were conducted, age range, mean age and 
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genders of study participants, total number and 
number of women and men separately with high and 
normal homocysteine levels and total number and 
number of men and women with high and normal 
homocysteine who have suffered a stroke were 
performed by two reviewers (A.S and P.P). The 
extracted data was reviewed by the third reviewer 




After searching for the keywords "Homocysteine," 
"Hcy," "plasma Homocysteine," "plasma Hcy," 
"ischemic stroke," "cerebral ischemia," "brain 
ischemia," and "stroke" in PubMed, web of science, 
Scopus, Science Direct and Google scholar databases, 
3884 articles were obtained.  First, 1086 duplicate 
articles were identified and deleted. The titles and 
abstracts of 2798 articles were carefully studied and 
reviewed. Studies that did not have titles and abstracts 
related to our topic and purpose were excluded from 
case report articles, letters to the editor, 
commentaries, editorials, Case series, animal studies, 
conference abstracts, and articles other than English. 
Three hundred-one articles were selected for full-text 
review, their full-text was carefully reviewed, and if 
there was data needed for extraction, the articles were 
selected for inclusion in the study. Finally, nine 
studies were selected for data extraction, and the 
required data were entered in a pre-prepared table. 
The process of searching and selecting studies is 




Figure 1. The diagram of the study. 
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Of the nine selected studies was a clinical trial 
(13) and eight observational studies (12, 14, and 18-
23), and in total, there were 16227 participants in 
these studies. Homocysteine levels were normal in 
10,738 people, and homocysteine levels were high in 
5489 people, the number of participants in each study 
ranged from 85 to 5935, and male and female genders 
were present in all studies. The age range of the 
participants was over 18 years, and their mean age 
was 59.7±11.3. Most studies have been done in 
China, one of the reasons being the high mortality rate 
due to stroke in China; a study by Donkor et al. 
Shows that the death rate due to stroke in China per 
100,000 people is 151 to 251 people (24). A summary 
of the characteristics of the nine articles used in this 
study is shown in Table 2. 
 
Prevalence of ischemic stroke: Of the nine studies 
selected, data from 8 studies show that the rate of 
ischemic stroke is higher in people with high 
homocysteine levels (12, 13, and 18-23). However, in 
one study, the rate of ischemic stroke was higher in 
people with normal homocysteine levels than in 
people with high homocysteine (14). The overall 
prevalence of ischemic stroke was 11.3%, and the 
prevalence of ischemic stroke was 14.1% in people 
with high homocysteine and 9.8% in people with 
normal homocysteine levels. The highest prevalence 
of ischemic stroke was 73.3%, which was related to 
people with high homocysteine levels (22) and the 
lowest prevalence was 2.6%, which was related to 
people with normal homocysteine levels (20). 
 
Differences in the prevalence of ischemic stroke in 
men and women: In only four studies, the prevalence 
of IS in men and women with high and normal 
homocysteine levels were reported separately (12, 13, 
18, and 20).  In other studies, the prevalence has 
generally been expressed, and the prevalence of IS in 
men and women cannot be extracted separately. In 
these four studies, the prevalence of IS was generally 
higher in both men and women with hHcy than in 
men and women with nHcy. The prevalence of IS in 
men and women with hHcy and nHcy was 11% vs. 
7.5% and 12% vs. 5.2%, respectively. Data from four 
studies show that the prevalence of IS is generally 
higher in men than in women (9.2% vs. 6.5%). 
 
Discussion 
This study aimed to investigate the relationship 
between homocysteine levels and the prevalence of IS 
using a systematic review method. Nowadays, 
increased plasma total homocysteine levels are 
considered as one of the reasons that are independent 
of other cerebrovascular risk factors such as 
hypertension, smoking, age, body mass index, 
diabetes, creatinine, high-density lipoprotein 
cholesterol levels, alcohol consumption, and Social 
class can increase a person's risk of stroke (25-27). 
Results of this systematic review study show that 
elevated total plasma homocysteine levels can be a 
risk factor for IS, and it also shows that the 
prevalence of IS is generally higher in people with 
hHcy than in people with nHcy. According to the 
results of this study, the prevalence of IS is generally 
higher in men; a study by Wang et al., Which 
examined the relationship between gender and the 
prevalence of stroke, confirms this finding (28-31). 
However, it should be noted that the prevalence of IS  
Table 1: PICOT (Population, Intervention, Comparison, Outcome, Time) criteria for inclusion of studies. 
Parameter Inclusion Criteria 
Population Adults (18≤ ) 
Intervention Hyperhomocysteinemia 
Comparison Hyperhomocysteinemia vs. Normal homocysteine levels 
Outcome Risk of ischemic stroke event 
Time The last 15 years (2020-2005) 
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is slightly higher in women with hHcy than men with 
hHcy (12% vs. 11%).  
In 2005 a study by Bos et al., in the 
Netherlands among people under the age of 45 (23) 
was performed that the results show the prevalence of 
IS was higher in people with hHcy. Bos study used 
people under the age of 45, and the mean age of the 
participants was 36.6 (23), while in most studies, the 
mean age of the participants was over 55 years. In the 
study by Cui et al., Which had a higher mean age than 
the other studies (68.2 years), the prevalence of 
ischemic stroke was higher in people with hHcy than 
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Ref: Reference; hHcy: high homocysteine level; nHcy: normal homocysteine level  
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in people with nHcy (21), so it seems that increased 
homocysteine can be a risk factor for increasing the 
risk of IS in adults (18≤), regardless of age. 
Among the selected studies, four have been 
performed in China (12, 13, 18, and 20); the 
importance of conducting this study in China is 
because China has the highest incidence of stroke 
with standardized age in the world (32). These studies 
can be very effective in identifying the risk factors for 
stroke, especially modifiable risk factors, to prevent 
the further prevalence of the stroke. The results of 
studies conducted in China show that the prevalence 
of IS is higher in people with hHcy than in people 
with nHcy (12, 13, 18, and 20). In 3 studies, the 
prevalence of IS was higher in women with hHcy 
than in men with hHcy (12, 18, and 20), but in one 
study, the prevalence of IS was higher in men with 
hHcy than in women. The prevalence of IS was 
higher in men with nHcy in 2 studies than women 
with nHcy (12, 13), and in 2 studies, women were 
more than men (18, 20). 
The results of a study by Angelova et al. show 
that the prevalence of IS is higher in people with high 
homocysteine levels than in people with nHcy (22); 
the results of the study by Choi et al., conducted in 
South Korea, also confirm the association between 
homocysteine levels and IS (19). It should be noted 
that the results of the study by Hultdin et al. show that 
the prevalence of ischemic stroke is slightly higher in 
people with nHcy than in people with hHcy, but the 
difference was not significant (14). 
The present systematic review study has some 
limitations, the number of cohort studies in this field 
is not enough, so due to the importance of the topic of 
stroke, it is necessary to conduct more cohort studies 
in this field to examine and conclude this topic more 
carefully. Also, due to the lack of access to the 
Embase database, we could not search for keywords 
in this database. Studies have been conducted in a 
limited number of countries, including four studies in 
China (12, 13, 18, and 20) and other studies in South 
Korea (19), Sweden (14), Japan (21), Bulgaria (22) 
and The Netherlands (23), which covers only the 
regions of East Asia and Eastern and Western Europe. 
For a more accurate and better conclusion, it is 
necessary to conduct this study in other countries. 
 
Conclusion    
The results of this study could confirm the association 
between homocysteine levels and the risk of IS. 
Therefore, it is necessary to use an appropriate diet to 
treat high homocysteine levels and consume enough 
calories and animal proteins (33-36). Deficiency of 
folic acid or vitamin B12 can also increase 
homocysteine levels and cause 
Hyperhomocysteinemia in a person; high 
homocysteine levels due to folic acid or vitamin B12 






Conflicts of Interest  




1. Fricker M, Tolkovsky AM, Borutaite V, Coleman M, Brown GC. 
Neuronal Cell Death. Physiol Rev. 2018;98(2):813-80. 
2. Béjot Y, Daubail B, Giroud M. Epidemiology of stroke and 
transient ischemic attacks: Current knowledge and perspectives. Rev 
Neurol (Paris). 2016;172(1):59-68. 
3. Grysiewicz RA, Thomas K, Pandey DK. Epidemiology of 
ischemic and hemorrhagic stroke: incidence, prevalence, mortality, 
and risk factors. Neurol Clin. 2008;26(4):871-95, vii. 
4. Randolph SA. Ischemic Stroke. Workplace Health Saf. 
2016;64(9):444. 
5. Boehme AK, Esenwa C, Elkind MS. Stroke Risk Factors, 
Genetics, and Prevention. Circ Res. 2017;120(3):472-95. 
6. Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz 
MI, Ezekowitz MD, et al. Guidelines for the prevention of stroke in 
patients with stroke and transient ischemic attack: a guideline for 
healthcare professionals from the American Heart 
Association/American Stroke Association. Stroke. 2014;45(7):2160-
236. 
7. Allen CL, Bayraktutan U. Risk factors for ischaemic stroke. Int J 
Stroke. 2008;3(2):105-16. 
8. Harris S, Kurniawan M, Rasyid A, Mesiano T, Hidayat R. 
Cerebral small vessel disease in Indonesia: Lacunar infarction study 
from Indonesian Stroke Registry 2012-2014. SAGE Open Med. 
2018;6:2050312118784312. 
9. Jackson C, Sudlow C. Are lacunar strokes really different? A 
Homocysteine Levels and Ischemic Stroke: A Systematic Review                                                                                    Pezeshgi et al. 
Vol 6, No 3, Summer 2021 
275 
systematic review of differences in risk factor profiles between 
lacunar and nonlacunar infarcts. Stroke. 2005;36(4):891-901. 
10. Sen U, Tyagi SC. Homocysteine and Hypertension in Diabetes: 
Does PPARgamma Have a Regulatory Role? PPAR Res. 
2010;2010:806538.Humphrey LL, Fu R, Rogers K, et al. 
Homocysteine level and coronary heart disease incidence: a 
systematic review and metaanalysis. Mayo Clin Proc. 
2008;83:1203–12. 
11. Wang C, Han L, Wu Q, Zhuo R, Liu K, Zhao J, et al. 
Association between homocysteine and incidence of ischemic stroke 
in subjects with essential hypertension: a matched case-control 
study. Clin Exp Hypertens. 2015;37(7):557-62. 
12. Li J, Wang Y, Li H, Zuo Z, Lin J, Wang A, et al. Homocysteine 
Level Predicts Response to Dual Antiplatelet in Women With Minor 
Stroke or Transient Ischemic Attack: Subanalysis of the CHANCE 
Trial. Arterioscler Thromb Vasc Biol. 2020;40(3):839-46. 
13. Hultdin J, Van Guelpen B, Winkvist A, Hallmans G, Weinehall 
L, Stegmayr B, et al. Prospective study of first stroke in relation to 
plasma homocysteine and MTHFR 677C>T and 1298A>C 
genotypes and haplotypes - evidence for an association with 
hemorrhagic stroke. Clin Chem Lab Med. 2011;49(9):1555-62. 
14. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting 
items for systematic reviews and meta-analyses: the PRISMA 
statement. PLoS Med. 2009;6(7):e1000097. 
15. Pratoomsoot C, Sruamsiri R, Dilokthornsakul P, 
Chaiyakunapruk N. Quality of reporting of randomised controlled 
trials of herbal interventions in ASEAN Plus Six Countries: a 
systematic review. PLoS One. 2015;10(1):e108681. 
16. Cuschieri S. The STROBE guidelines. Saudi J Anaesth. 
2019;13(Suppl 1):S31-s4. 
17. Han L, Wu Q, Wang C, Hao Y, Zhao J, Zhang L, et al. 
Homocysteine, Ischemic Stroke, and Coronary Heart Disease in 
Hypertensive Patients: A Population-Based, Prospective Cohort 
Study. Stroke. 2015;46(7):1777-86. 
18. Choi SH, Choi-Kwon S, Kim MS, Kim JS. Poor nutrition and 
alcohol consumption are related to high serum homocysteine level at 
post-stroke. Nutr Res Pract. 2015;9(5):503-10. 
19. Wang CY, Chen ZW, Zhang T, Liu J, Chen SH, Liu SY, et al. 
Elevated plasma homocysteine level is associated with ischemic 
stroke in Chinese hypertensive patients. Eur J Intern Med. 
2014;25(6):538-44. 
20. Cui R, Moriyama Y, Koike KA, Date C, Kikuchi S, Tamakoshi 
A, et al. Serum total homocysteine concentrations and risk of 
mortality from stroke and coronary heart disease in Japanese: The 
JACC study. Atherosclerosis. 2008;198(2):412-8. 
21. Angelova EA, Atanassova PA, Chalakova NT, Dimitrov BD. 
Associations between serum selenium and total plasma 
homocysteine during the acute phase of ischaemic stroke. Eur 
Neurol. 2008;60(6):298-303. 
22. Bos MJ, van Goor ML, Koudstaal PJ, Dippel DW. Plasma 
homocysteine is a risk factor for recurrent vascular events in young 
patients with an ischaemic stroke or TIA. J Neurol. 
2005;252(3):332-7. 
23. Donkor ES. Stroke in the 21(st) Century: A Snapshot of the 
Burden, Epidemiology, and Quality of Life. Stroke Res Treat. 
2018;2018:3238165. 
24. Bushnell CD, Goldstein LB. Homocysteine testing in patients 
with acute ischemic stroke. Neurology. 2002;59(10):1541-6. 
25. Pezzini A, Grassi M, Del Zotto E, Assanelli D, Archetti S, 
Negrini R, et al. Interaction of homocysteine and conventional 
predisposing factors on risk of ischaemic stroke in young people: 
consistency in phenotype-disease analysis and genotype-disease 
analysis. J Neurol Neurosurg Psychiatry. 2006;77(10):1150-6. 
26. Marcus J, Sarnak MJ, Menon V. Homocysteine lowering and 
cardiovascular disease risk: lost in translation. Can J Cardiol. 
2007;23(9):707-10. 
27. Liu L, Teng J, Ma M, Guo L, Yang L, Gao J, et al. Serum 
homocysteine level is an independent predictor for hemorrhagic 
transformation within 24 h of intravenous thrombolysis in acute 
ischemic stroke. J Clin Neurosci. 2020;82(Pt A):13-9. 
28. Boysen G, Brander T, Christensen H, Gideon R, Truelsen T. 
Homocysteine and risk of recurrent stroke. Stroke. 2003;34(5):1258-
61. 
29. Global, regional, and national age-sex-specific mortality for 282 
causes of death in 195 countries and territories, 1980-2017: a 
systematic analysis for the Global Burden of Disease Study 2017. 
Lancet. 2018;392(10159):1736-88. 
30. Shi Z, Guan Y, Huo YR, Liu S, Zhang M, Lu H, et al. Elevated 
Total Homocysteine Levels in Acute Ischemic Stroke Are 
Associated With Long-Term Mortality. Stroke. 2015;46(9):2419-25. 
31. Caso V, Paciaroni M. MTHFR 677 TT genotype and 
hyperhomocysteinaemia: an underestimated risk TANDEM for 
patients with stroke. J Neurol Neurosurg Psychiatry. 
2006;77(10):1103. 
32. Virtanen JK, Voutilainen S, Happonen P, Alfthan G, Kaikkonen 
J, Mursu J, et al. Serum homocysteine, folate and risk of stroke: 
Kuopio Ischaemic Heart Disease Risk Factor (KIHD) Study. Eur J 
Cardiovasc Prev Rehabil. 2005;12(4):369-75. 
33. Wang Y, Dai Y, Zheng J, Xie Y, Guo R, Guo X, et al. Sex 
difference in the incidence of stroke and its corresponding influence 
factors: results from a follow-up 8.4 years of rural China 
hypertensive prospective cohort study. Lipids Health Dis. 
2019;18(1):72. 
34. Pisu M, Richman JS, Martin RC, Kim Y, Kratt P, Clements K, 
et al. Diagnostic tests and neurology care for Medicare beneficiaries 
with seizures: differences across racial groups. Med Care. 
2012;50(8):730-6. 
35. Bigi S, Fischer U, Wehrli E, Mattle HP, Boltshauser E, Bürki S, 
et al. Acute ischemic stroke in children versus young adults. Ann 
Neurol. 2011;70(2):245-54. 
36. Hart RG, Miller VT. Cerebral infarction in young adults: a 
practical approach. Stroke. 1983;14(1):110-4. 
37. Global, regional, and national burden of stroke, 1990-2016: a 
systematic analysis for the Global Burden of Disease Study 2016. 
Lancet Neurol. 2019;18(5):439-58. 
38. Spence JD. Homocysteine lowering for stroke prevention: 
Unravelling the complexity of the evidence. Int J Stroke. 
2016;11(7):744-7.
 
